Recombinant N. europaea DXR is a genetically engineered form of the enzyme produced in Escherichia coli. It retains the catalytic activity of the native enzyme while enabling scalable purification via a C-terminal His-tag . The MEP pathway bypasses the mevalonate pathway used by humans, making DXR a potential antibacterial and antimalarial drug target .
DXR performs two sequential reactions:
Isomerization: Rearrangement of DXP into 2-C-methyl-D-erythrose 4-phosphate.
Reduction: NADPH-dependent reduction to form MEP .
The reaction is irreversible, committing carbon flux toward isoprenoid precursors like isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) .
Fosmidomycin, a phosphonic acid antibiotic, competitively inhibits DXR by mimicking the substrate’s phosphate group . This inhibition validates DXR as a target for novel antimicrobials, particularly against pathogens relying on the MEP pathway (e.g., Plasmodium falciparum) .
Proteomic studies revealed that N. europaea DXR abundance decreases by 50% under high salinity (30 mS cm⁻¹), suggesting metabolic reallocation during osmotic stress . This contrasts with upregulated oxidative stress response proteins, indicating prioritized survival mechanisms over isoprenoid biosynthesis .
Drug Development: DXR’s absence in humans makes it a prime target for antibiotics and herbicides .
Metabolic Engineering: Recombinant DXR enables pathway optimization for microbial production of isoprenoids (e.g., terpenes) .
While N. europaea primarily relies on chemolithoautotrophic ammonia oxidation for energy, the MEP pathway supplies isoprenoids for:
N. europaea DXR shares functional homology with orthologs in other bacteria (e.g., E. coli) but exhibits distinct regulatory responses to environmental stressors like salinity . Unlike denitrifiers, N. europaea lacks dissimilatory nitrate reductases, emphasizing its reliance on ammonia oxidation and the MEP pathway for redox balance .
Further studies should explore:
KEGG: neu:NE1712
STRING: 228410.NE1712
DXR catalyzes the second step in the methylerythritol phosphate (MEP) pathway for isoprenoid biosynthesis. It converts 1-deoxy-D-xylulose 5-phosphate (DXP) into 2-C-methyl-D-erythritol 4-phosphate (MEP) through an isomerization followed by a NADPH-dependent reduction . In Nitrosomonas europaea, this pathway is critical for the production of essential isoprenoid compounds needed for cell membrane integrity and various cellular processes, enabling this chemolithoautotrophic ammonia-oxidizing bacterium to maintain its unique metabolic functions.
While the specific relationship between DXR and nitrification processes in N. europaea isn't directly described in available literature, the MEP pathway in which DXR functions represents a crucial metabolic route that likely supports the specialized energy metabolism of this organism. N. europaea generates energy primarily through the oxidation of ammonia to nitrite , and the isoprenoids produced via the MEP pathway likely contribute to maintaining cellular structures necessary for this chemolithoautotrophic lifestyle. The regulation of DXR may be integrated with other metabolic pathways that respond to environmental conditions such as oxygen availability and nitrite concentration, which are known to affect gene expression patterns in N. europaea .
Similar to other functional genes in N. europaea, the dxr gene likely has specific regulatory elements that respond to the organism's unique environmental adaptations. N. europaea is known to regulate gene expression in response to environmental factors such as dissolved oxygen levels and nitrite concentrations . When working with the dxr gene, researchers should consider potential regulatory interactions with other metabolic pathways, especially considering that N. europaea has evolved complex gene clusters such as those observed with nirK and associated genes (ncgABC) that work together functionally .
When expressing recombinant N. europaea DXR, researchers should consider the following methodological approaches:
Expression system selection: E. coli BL21(DE3) or similar strains are typically suitable for expressing bacterial enzymes like DXR.
Codon optimization: N. europaea has distinct codon usage patterns that may require optimization for efficient expression in heterologous hosts.
Expression conditions: Based on knowledge of other N. europaea proteins, optimal expression may require:
Induction at lower temperatures (16-25°C)
Extended expression periods (18-24 hours)
IPTG concentrations of 0.1-0.5 mM
Vector design: Incorporating affinity tags (His6, GST) while ensuring they don't interfere with the active site is crucial for downstream purification.
Researchers should monitor expression levels through SDS-PAGE and Western blot analysis, similar to methods used for monitoring NirK expression in N. europaea mutants .
Purification of recombinant N. europaea DXR presents several challenges requiring strategic approaches:
Maintaining enzyme stability: Buffer optimization is critical, typically requiring:
pH maintenance between 7.0-8.0
Inclusion of glycerol (10-20%)
Addition of reducing agents (DTT or β-mercaptoethanol)
Potential inclusion of divalent cations (Mg²⁺ or Mn²⁺)
Solubility issues: N. europaea proteins may have unique solubility properties requiring:
Solubility screening with different detergents if membrane association occurs
Optimization of salt concentrations (typically 100-300 mM NaCl)
Purification strategy:
Initial capture: affinity chromatography (IMAC for His-tagged constructs)
Intermediate purification: ion exchange chromatography
Polishing: size exclusion chromatography to obtain homogenous enzyme preparations
Protein quality should be assessed through activity assays specific to DXR function, ensuring the conversion of DXP to MEP in the presence of NADPH .
For structural studies requiring isotope-labeled DXR, researchers should implement the following methodology:
Minimal media formulation optimized for N. europaea protein expression:
M9 minimal media supplemented with trace elements
¹⁵N-ammonium chloride for nitrogen labeling
¹³C-glucose or ¹³C-glycerol for carbon labeling
Deuterated water (D₂O) for deuterium labeling if required
Expression protocol modifications:
Extended adaptation periods in isotope-containing media
Lower growth temperatures (16-20°C)
Longer induction times with reduced IPTG concentrations
Potential supplementation with amino acids for selective labeling
Verification methods:
Mass spectrometry to confirm incorporation levels
Preliminary NMR tests to assess spectral quality before full structural studies
This approach allows for the production of labeled DXR suitable for NMR spectroscopy or neutron diffraction studies, enabling detailed analysis of structural dynamics and catalytic mechanisms.
DXR activity can be measured using several complementary approaches:
Spectrophotometric NADPH oxidation assay:
Monitors decrease in absorbance at 340 nm
Reaction mixture contains:
Purified recombinant DXR
DXP substrate (typically 0.1-1 mM)
NADPH (0.1-0.2 mM)
Buffer (typically HEPES or Tris, pH 7.5-8.0)
Divalent cation (usually Mg²⁺ or Mn²⁺, 1-5 mM)
Activity calculated using NADPH extinction coefficient (ε₃₄₀ = 6,220 M⁻¹cm⁻¹)
HPLC-based product formation assay:
Directly quantifies MEP production
Reaction stopped with acid or heat
Products separated by reverse-phase HPLC
Detection by UV absorbance or coupled to mass spectrometry
Coupled enzyme assays:
Links MEP formation to a secondary enzyme reaction with colorimetric or fluorescent output
Useful for high-throughput screening applications
Similar to approaches used in studying NirK activity in N. europaea , controls should include enzyme-free and substrate-free reactions, with validation using known DXR inhibitors such as fosmidomycin .
Based on N. europaea's environmental adaptations, the following parameters should be systematically evaluated:
Temperature effects:
| Temperature (°C) | Expected Relative Activity (%) |
|---|---|
| 4 | 10-20 |
| 20 | 40-60 |
| 30 | 80-100 |
| 40 | 60-80 |
| 50 | 20-40 |
pH dependency:
| pH | Expected Relative Activity (%) |
|---|---|
| 6.0 | 30-50 |
| 7.0 | 70-90 |
| 7.5 | 90-100 |
| 8.0 | 80-100 |
| 9.0 | 40-60 |
Oxygen sensitivity: Given N. europaea's adaptations to varying oxygen levels , monitor:
Activity under aerobic vs. microaerobic conditions
Potential oxidative inactivation during extended reactions
Effects of oxygen scavengers on enzyme stability
Ionic strength and cation requirements:
Test range of Mg²⁺ and Mn²⁺ concentrations (0.5-10 mM)
Evaluate effects of monovalent cations (K⁺, Na⁺)
Determine optimal ionic strength for maximal activity
These environmental parameters should be systematically tested using the aforementioned activity assays to establish optimal conditions for enzymatic studies.
Comprehensive analysis of substrate specificity and inhibition requires:
Substrate specificity assessment:
Test DXP analogs with modifications at specific positions
Determine kinetic parameters (Km, kcat, kcat/Km) for each substrate
Create a structure-activity relationship table correlating molecular features with catalytic efficiency
Inhibition studies methodology:
Establish IC₅₀ values for known DXR inhibitors (fosmidomycin, FR900098)
Determine inhibition mechanisms through:
Lineweaver-Burk plots
Dixon plots
Cornish-Bowden plots
Classify inhibitors as competitive, uncompetitive, or mixed
Data analysis template:
| Inhibitor | IC₅₀ (μM) | Ki (μM) | Inhibition Type | Structure-Activity Relationship Notes |
|---|---|---|---|---|
| Fosmidomycin | [value] | [value] | Competitive | Phosphonate group essential |
| FR900098 | [value] | [value] | Competitive | N-acetyl modification increases potency |
| [Custom inhibitor] | [value] | [value] | [type] | [observations] |
Correlation with other N. europaea enzymes: Compare inhibition patterns with other N. europaea enzymes to identify potential metabolic vulnerabilities, similar to approaches used in studying NirK inhibition .
When analyzing the structural features of N. europaea DXR, researchers should focus on:
Domain organization comparison:
Active site architecture analysis:
Identification of catalytic residues through sequence alignment and structural modeling
Comparison with the conserved catalytic triad found in most DXR enzymes
Potential adaptations specific to N. europaea's ecological niche
Oligomeric state determination:
Size exclusion chromatography to determine native molecular weight
Analytical ultracentrifugation to confirm oligomerization state
Cross-linking studies to identify intersubunit interactions
Structural flexibility assessment:
Hydrogen-deuterium exchange mass spectrometry to identify regions of conformational flexibility
Molecular dynamics simulations to predict domain movements during catalysis
Comparison with conformational changes observed in related DXR enzymes
Understanding these structural features within the context of N. europaea's unique physiological adaptations could reveal novel aspects of DXR function in chemolithoautotrophic bacteria.
Computational methods offer valuable insights into DXR function:
Homology modeling workflow:
Template selection based on sequence identity with known DXR structures
Model building using multiple templates when available
Refinement focusing on active site geometry
Validation through energy minimization and Ramachandran plot analysis
Comparison with experimental data when available
Molecular dynamics simulation protocol:
System preparation with proper protonation states and solvation
Energy minimization and equilibration
Production runs (minimum 100 ns) under various conditions
Analysis of:
Active site flexibility
Water-mediated interactions
Conformational changes during substrate binding
Effects of pH and temperature on structure
Quantum mechanics/molecular mechanics (QM/MM) approaches:
QM treatment of the active site and substrate
MM treatment of the protein environment
Calculation of reaction energy profiles
Identification of transition states and intermediates
Integration with experimental data:
Validation using site-directed mutagenesis results
Refinement based on spectroscopic measurements
Correlation with inhibition patterns
These computational approaches can provide valuable insights similar to those that helped understand the functional interactions between NirK and other proteins in N. europaea .
Several spectroscopic techniques provide complementary insights:
Circular dichroism (CD) spectroscopy applications:
Secondary structure composition assessment (190-260 nm)
Thermal stability determination through melting curves
Conformational changes upon substrate/inhibitor binding
Effects of pH, ionic strength, and temperature on structure
Fluorescence spectroscopy approaches:
Intrinsic tryptophan fluorescence to monitor conformational changes
Binding studies using:
Fluorescence quenching
Fluorescence anisotropy
Förster resonance energy transfer (FRET)
Cofactor binding kinetics (NADPH association/dissociation)
NMR spectroscopy applications:
Backbone assignments of labeled protein
Chemical shift perturbation experiments to map binding interfaces
Relaxation measurements to assess protein dynamics
Hydrogen-deuterium exchange to identify protected regions
EPR spectroscopy for metal interactions:
Characterization of metal cofactor binding
Spin-labeling of specific residues to monitor conformational changes
Detection of potential radical intermediates during catalysis
Each technique should be applied in conjunction with activity assays to correlate structural observations with functional outcomes, similar to approaches linking NirK structure with its physiological role in N. europaea .
Metabolic integration hypothesis:
The MEP pathway likely interfaces with N. europaea's core energy metabolism, which relies on ammonia oxidation to nitrite for energy generation . DXR activity may be coordinated with:
Ammonia monooxygenase (AMO) activity
Hydroxylamine oxidoreductase (HAO) function
Respiratory electron transport chain components
Stress response connections:
N. europaea is known to regulate gene expression in response to environmental stressors . DXR activity might be modulated under:
Oxygen limitation conditions
High nitrite concentrations
Nutrient limitation
pH stress
Integration with nitrite detoxification mechanisms:
N. europaea expresses NirK and other proteins for nitrite tolerance . DXR-dependent isoprenoid production may support:
Membrane integrity under nitrite stress
Production of specialized lipids for stress tolerance
Synthesis of molecules involved in signaling pathways
Understanding these relationships requires correlation of DXR activity with transcriptional data for key metabolic genes (amoA, hao, nirK, norB) under various environmental conditions .
N. europaea shows complex transcriptional responses to varying oxygen levels , suggesting potential impacts on DXR function:
Oxygen limitation responses:
When oxygen is limited, N. europaea increases transcription of ammonia oxidation genes (amoA, hao) , which may correlate with:
Altered DXR expression to support membrane adaptations
Modified isoprenoid production patterns
Shifts in metabolic pathway integration
Potential regulatory mechanisms:
Transcriptional regulation similar to other metabolic genes
Post-translational modifications affecting enzyme activity
Allosteric regulation by metabolic intermediates
Protein-protein interactions modulating function
Experimental approach to investigate oxygen effects:
Controlled batch cultures at defined dissolved oxygen concentrations
Measurement of dxr transcript levels via RT-qPCR
Analysis of DXR protein levels and activity
Correlation with isoprenoid production profiles
Expected patterns based on N. europaea physiology:
| Oxygen Condition | Expected DXR Expression | Potential Metabolic Significance |
|---|---|---|
| Oxygen-rich | Baseline expression | Normal isoprenoid production |
| Oxygen-limited | Potentially increased | Support for membrane adaptations |
| Anaerobic stress | Regulatory shift | Integration with alternative respiratory pathways |
These hypotheses can be tested using approaches similar to those used for studying other N. europaea genes under varying oxygen conditions .
N. europaea has evolved specific mechanisms to tolerate the nitrite it produces , which may involve DXR:
Nitrite stress response patterns:
Experimental design to assess nitrite effects on DXR:
Expected relationship with nitric oxide detoxification:
Mitigation strategies for nitrite inhibition in enzymatic assays:
Buffer optimization to minimize nitrite interference
Control experiments with known nitrite concentrations
Correlation of in vitro vs. in vivo effects of nitrite on DXR function
These investigations would build upon existing knowledge of N. europaea's nitrite tolerance mechanisms .
Researchers frequently encounter several challenges when working with recombinant N. europaea DXR:
Low expression levels:
Solution: Optimize codon usage for expression host
Solution: Test multiple fusion tags (His, GST, MBP)
Solution: Evaluate different promoter systems
Solution: Screen expression conditions (temperature, induction time, media composition)
Inclusion body formation:
Solution: Lower induction temperature (16-20°C)
Solution: Reduce inducer concentration
Solution: Co-express with molecular chaperones (GroEL/ES, DnaK/J)
Solution: Add solubility-enhancing agents to culture medium (sorbitol, arginine)
Protein instability:
Solution: Include protease inhibitors throughout purification
Solution: Add stabilizing agents (glycerol, reducing agents)
Solution: Maintain cold temperatures during all processing steps
Solution: Consider on-column refolding protocols if necessary
Loss of activity during purification:
Solution: Minimize purification steps
Solution: Test activity after each purification stage
Solution: Include cofactors (NADPH) or substrate analogs in buffers
Solution: Optimize buffer compositions (pH, ionic strength, additives)
Each challenge should be systematically addressed with controlled experiments to identify optimal conditions.
When facing inconsistent kinetic measurements:
Enzyme quality issues:
Verification: Check protein homogeneity by SDS-PAGE and size exclusion chromatography
Solution: Implement more stringent purification protocols
Solution: Prepare fresh enzyme preparations more frequently
Solution: Determine optimal storage conditions through stability tests
Assay interference factors:
Verification: Run control reactions with known DXR enzymes from other sources
Solution: Test multiple buffer systems to identify interference
Solution: Filter or treat reagents to remove potential contaminants
Solution: Validate assays with orthogonal methods (spectrophotometric vs. HPLC)
Data analysis approach:
Verification: Apply multiple fitting methods to the same dataset
Solution: Use global fitting approaches for complex kinetic models
Solution: Implement statistical analyses to identify outliers
Solution: Conduct sufficient replicates (minimum n=3) for each measurement
Environmental variables:
Verification: Monitor temperature stability during reactions
Solution: Control oxygen exposure throughout experiments
Solution: Standardize reagent preparation protocols
Solution: Consider microplate reader calibration if using high-throughput formats
Documenting all experimental conditions and variables is crucial for identifying the source of inconsistency.
For researchers pursuing structural studies:
Protein sample optimization:
Strategy: Further purification steps (ion exchange, size exclusion)
Strategy: Limited proteolysis to remove flexible regions
Strategy: Surface entropy reduction through engineered mutations
Strategy: Thermal stability screening to identify stabilizing conditions
Crystallization condition screening:
Strategy: Expanded commercial screen testing (500+ conditions)
Strategy: Systematic grid screens around promising conditions
Strategy: Inclusion of substrate, cofactor, or inhibitors as stabilizing ligands
Strategy: Testing various protein concentrations (5-20 mg/mL)
Alternative crystallization approaches:
Strategy: Lipidic cubic phase for membrane-associated forms
Strategy: Microseeding from initial crystal hits
Strategy: Batch crystallization versus vapor diffusion
Strategy: Counter-diffusion methods in capillaries
Construct optimization:
Strategy: Test multiple N- and C-terminal truncations
Strategy: Surface cysteine mutations to prevent non-specific aggregation
Strategy: Co-crystallization with antibody fragments
Strategy: Domain-swapping approaches with crystallizable homologs
These approaches have proven successful with challenging proteins and could be adapted specifically for N. europaea DXR.